| 注册
首页|期刊导航|中国感染控制杂志|艰难梭菌复发感染的早期识别和合理治疗

艰难梭菌复发感染的早期识别和合理治疗

李文君 陆鑫 权敏 黄文治 王晓辉

中国感染控制杂志2025,Vol.24Issue(7):883-889,7.
中国感染控制杂志2025,Vol.24Issue(7):883-889,7.DOI:10.12138/j.issn.1671-9638.20252062

艰难梭菌复发感染的早期识别和合理治疗

Early identification and rational treatment of recurrent Clostridioides difficile infection

李文君 1陆鑫 1权敏 1黄文治 2王晓辉3

作者信息

  • 1. 四川大学华西医院感染性疾病中心,四川成都 610041
  • 2. 四川大学华西医院医院感染管理部,四川成都 610041
  • 3. 四川大学华西医院感染性疾病中心,四川成都 610041||四川大学华西医院病原微生物研究中心,四川成都 610041
  • 折叠

摘要

Abstract

To analyze the clinical data of patients with recurrent Clostridioides difficile infection(rCDI)in the southwestern region,and help clinicians identify high-risk populations early and adopt appropriate treatment strate-gies.Methods Clinical data of rCDI cases from a tertiary first-class hospital in southwest China from July 2019 to June 2024 were collected,and their host-related risk factors,exogenous risk factors,treatment schemes,and end-point outcomes were analyzed.Results In the past five years,a total of 26 cases of rCDI were detected from a ter-tiary first-class hospital in southwest China,accounting for 4.04%of the total positive cases(n=643)detected during the same period.19.23%of the recurrent patients experienced a second recurrence.The median age of rCDI patients was 66.5 years old,with males accounting for 73.08%.The major comorbidity included diabetes mellitus(34.62%),malignant tumors(30.77%),and chronic renal diseases(23.08%).In the 8 weeks before the first on-set of rCDI in patients,the top three drugs used were β-lactam and enzyme inhibitor compound(69.23%),proton pump inhibitors(65.38%),and carbapenems(46.15%).In the initial treatment of recurrent patients,3.85%(1/26)of the cases were treated with metronidazole,19.23%(5/26)of the cases received non-standard vancomy-cin/norvancomycin treatment in usage or dosage,46.15%(12/26)of the cases received treatment with course less than 10 days.In the treatment of the first recurrence,34.78%(8/26)of the cases received treatment with course less than 10 days.Conclusion For elderly patients and patients with diabetes mellitus,malignant tumors,and chronic renal diseases,who have used β-lactam and enzyme inhibitor compound,proton pump inhibitors,carbapene-ms within 8 weeks before disease onset,standard dose and treatment course of vancomycin or norvancomycin are recommended under permitted conditions,so as to reduce the risk of recurrence.

关键词

艰难梭菌复发感染/临床特征/危险因素/合理治疗/CDI

Key words

recurrent Clostridioides difficile infection/clinical characteristics/risk factor/rational treatment/CDI

分类

医药卫生

引用本文复制引用

李文君,陆鑫,权敏,黄文治,王晓辉..艰难梭菌复发感染的早期识别和合理治疗[J].中国感染控制杂志,2025,24(7):883-889,7.

基金项目

国家自然科学基金面上项目(82072315) (82072315)

中国感染控制杂志

OA北大核心

1671-9638

访问量0
|
下载量0
段落导航相关论文